Company / Revenue
IMMUCELL CORP /DE/ Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$26.5M
FY2025
5-year range
$9.5M / $26.5M
FY2021-FY2025
Trend
+51.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $4M in FY2012 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 10-year CAGR of +16.0%.
Improved from $19M to $26M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +16.0%
Key checks
Key Insights
- In FY2025, revenue increased 51.6% year-over-year.
- Lowest revenue in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.5M | +51.6% |
| FY2024 | $17.5M | -5.9% |
| FY2023 | $18.6M | +94.6% |
| FY2017 | $9.5M | -6.7% |
| FY2016 | $10.2M | +70.3% |
| FY2015 | $6.0M | +11.5% |
| FY2014 | $5.4M | +5.5% |
| FY2013 | $5.1M | +16.5% |
| FY2012 | $4.4M | -2.7% |
| FY2011 | $4.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026